Infection with hepatitis B and C viruses and human retroviruses (HTLV-I and HIV) among high-risk Lebanese patients

Annals of Tropical Medicine and Parasitology

Volumn 97, Issue 2, 2003, Pages 187-192

  Ramia, S ^a   Klayme, S ^b   Naman, R ^b  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b SAINT JOSEPH UNIVERSITY   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOPHILIA; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LEBANON; MAJOR CLINICAL STUDY; MALE; SEROPREVALENCE;

ADULT; ANTIBODIES, VIRAL; BIOLOGICAL MARKERS; BLOOD TRANSFUSION; FEMALE; GENOTYPE; HEMOPHILIA A; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HIV INFECTIONS; HTLV-I INFECTIONS; HUMANS; LEBANON; MALE; MIDDLE AGED; NEOPLASMS; RISK FACTORS; RNA, VIRAL; SUBSTANCE-RELATED DISORDERS;

DNA VIRUSES; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN T-LYMPHOTROPIC VIRUS 1; RNA VIRUSES;

EID: 0038414773     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/000349803235001363     Document Type: Article

References (22)

1. Al-Faleh, F. Z. & Ramia, S. (1997). Hepatitis C virus (HCV) infection in Saudi Arabia: a review. Annals of Saudi Medicine, 17, 77-82.
2. Al-Faleh, F. Z., Huraib, S., Sbeih, F., Al-Karawi, M., Al-Rashed, R., Al-Mofleh, I. A., Sougiyyah, M., Shaheen, M. & Ramia, S. (1995). Hepatitis C virus genotypes in patients with chronic liver disease and hemodialysis patients from Saudi Arabia. Journal of Viral Hepatitis, 2, 293-296.
3. Al-Fawaz, I. & Ramia, S. (1993). Decline in hepatitis B infection in sickle cell anemia and β-thalassemia major. Archives of Disease in Childhood, 69, 594-596.
4. Al-Nozha, M., Ramia, S., El-Hazmi, M. A. F., Al-Mashhadani, S. & Babiker, M. A. (1987). AIDS virus antibody in the normal population and in three 'high risk' groups of Saudi patients: multi-transfused, hemophiliacs and chronic renal failure patients on hemodialysis. AIDS-Forschung, 2, 508-511.
5. Anon. (1988a). Ways to reduce the risk of transmission of viral infection by plasma and plasma products. Vox Sanguinis, 54, 228.
6. Anon. (1988b). Safety of therapeutic products used for hemophilia patients. Morbidity and Mortality Weekly Report, 37, 441-444, 449-450.
7. Bahakim, H., Bakir, T. M. F., Arif, M. & Ramia, S. (1991). Hepatitis C virus antibodies in high risk Saudi groups. Vox Sanguinis, 60, 162-164.
8. Bakir, T. M. F., Kurbaan, K. M., Al-Fawaz, I. & Ramia, S. (1995). Infection with hepatitis viruses (B and C and human retroviruses (HTLV-I and HIV) in Saudi children receiving cycled cancer chemotherapy. Journal of Tropical Pediatrics, 41, 206-209.
9. Eddleston, A. L. W. F. & Modelli, M. (1986). Immunopathological mechanism of liver injury in chronic hepatitis B virus infection. Journal of Hepatology, 3 (Suppl. 2), S17-S23.
10. Grumayer, E. R., Panzer, S., Ferenci, P. & Gander, H. (1989). Recurrence of hepatitis B in children with serologic evidence of past B virus infection undergoing anti-leukemic chemotherapy. Journal of Hepatology, 8, 232-235.
11. Guido, M., Rossetti, F., Rugge, M., Cesaro, S., Aneloni, V., Ninfo, V. & Zonesco, L. (1991). Leukemia and liver disease in childhood: clinical and histological evaluation. Tumori, 77, 319-322.
12. Hay, C. R. M., Preston, F. E., Triger, D. R. & Underwood, J. C. E. (1985). Progressive liver disease in haemophilia: an understated problem. Lancet, i, 1495.
13. Kanamori, H., Fukawa, H., Maruta, A., Harano, H., Kodama, F. & Matsuzaki, M. (1992). Case report: fulminant hepatitis C viral infection after allogeneic bone marrow transplantation. American Journal of Medical Sciences, 303, 109-111.
14. Locasciulli, A., Santamaria, M., Masera, G., Schiavon, E., Alberti, A. & Realdi, G. (1985). Hepatitis B virus markers in children with acute leukemia: the effect of chemotherapy. Journal of Medical Virology, 15, 29-33.
15. Mokhbat, J. E. & Naman, R. (1989). Clinical and serological study of human immunodeficiency virus infection in a cohort of multitransfused patients including patients on chronic hemodialysis. Lebanese Science Bulletin, 5, 15-22.
16. Naman, R., Klayme, S., Naboulsi, M., Mokhbat, J., Jradi, O. & Ramia, S. (2002). HTLV-I and HTLV-II infections in volunteer blood donors and high-risk groups in Lebanon. Journal of Infection, 45, 29-31.
17. Ramia, S., Koussa, S., Taher, A., Haraki, S., Klayme, S., Sarkis, D. & Naman, R. (2002). Hepatitis-C-virus genotypes and hepatitis-G-virus infection in Lebanese thalassaemics. Annals of Tropical Medicine and Parasitology, 96, 197-202.
18. Sansonno, D., Procaccio, P. & Dammacco, F. (1991). Kinetics of anti-hepatitis C virus response during acute hepatitis in an immuno-suppressed HCV chronically infected patient. Digestion, 50, 52-60.
19. Sheth, K. V., Amer, M., Al-Sedairy, S. & Abdulatif, M. A. (1990). Prevalence of anti-HTLV-1 antibodies in sera from 153 cases of non-Hodgkin's lymphoma. Annals of Saudi Medicine, 10, 626-628.
20. Tedder, R. S., Briggs, M., Ring, C., Tuke, P. W., Jones, P., Savidge, G. F., Rodgers, B. & Garson, J. A. (1991). Hepatitis C antibody profile and viraemia prevalence in adults with severe haemophilia. British Journal of Haematology, 79, 512.
21. Watson, H. G., Ludlam, C. A., Rebus, S., Zhang, L. Q., Peutherer, J. F. & Simmonds, P. (1992). Use of several second generation serological assays to determine the true prevalence of hepatitis C virus infection in haemophiliacs treated with non-virus inactivated factor VIII and IX concentrates. British Journal of Haematology, 80, 514.
22. Zein, N. N., Rakela, J., Krawitt, E. L., Reddy, K. R., Tominaga, T., Persing, D. H. & The Collaborative Study Group (1996). Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Annals of Internal Medicine, 125, 634-639.